CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 20 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $41,000 | +28.1% | 106,036 | +63.2% | 0.00% | – |
| Q4 2015 | $32,000 | -50.0% | 64,977 | -49.1% | 0.00% | – |
| Q3 2015 | $64,000 | -37.9% | 127,546 | -1.1% | 0.00% | – |
| Q2 2015 | $103,000 | -10.4% | 128,903 | +1.0% | 0.00% | – |
| Q1 2015 | $115,000 | +12.7% | 127,578 | -12.0% | 0.00% | – |
| Q4 2014 | $102,000 | -79.0% | 145,022 | -9.1% | 0.00% | – |
| Q3 2014 | $485,000 | +15.5% | 159,529 | +16.6% | 0.00% | – |
| Q2 2014 | $420,000 | -13.4% | 136,856 | +3.9% | 0.00% | – |
| Q1 2014 | $485,000 | -17.8% | 131,658 | -10.4% | 0.00% | – |
| Q4 2013 | $590,000 | -29.1% | 146,880 | -24.8% | 0.00% | – |
| Q3 2013 | $832,000 | -28.1% | 195,309 | +2.3% | 0.00% | – |
| Q4 2012 | $1,157,000 | – | 190,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,356,091 | $1,202,000 | 0.05% |
| VANGUARD GROUP INC | 6,177,466 | $156,921,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 17,500 | $8,000 | 0.00% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 12,000 | $6,000 | 0.00% |
| PACIFIC GLOBAL INVESTMENT MANAGEMENT CO | 10,000 | $5,000 | 0.00% |
| Glassman Wealth Services | 2,197 | $1,000 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,856 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $17,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,435 | $44,000 | 0.00% |